These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 19491109)
1. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. Kawanami D; Mahabeleshwar GH; Lin Z; Atkins GB; Hamik A; Haldar SM; Maemura K; Lamanna JC; Jain MK J Biol Chem; 2009 Jul; 284(31):20522-30. PubMed ID: 19491109 [TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α). Zhao G; Liu Y; Fang J; Chen Y; Li H; Gao K Biochem Biophys Res Commun; 2014 Jun; 448(3):303-7. PubMed ID: 24569076 [TBL] [Abstract][Full Text] [Related]
3. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells. Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883 [TBL] [Abstract][Full Text] [Related]
4. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765 [TBL] [Abstract][Full Text] [Related]
5. ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment. Zhu K; Jiao H; Li S; Cao H; Galson DL; Zhao Z; Zhao X; Lai Y; Fan J; Im HJ; Chen D; Xiao G J Bone Miner Res; 2013 Sep; 28(9):1870-1884. PubMed ID: 23649506 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048 [TBL] [Abstract][Full Text] [Related]
7. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes. Lee SH; Che X; Jeong JH; Choi JY; Lee YJ; Lee YH; Bae SC; Lee YM J Biol Chem; 2012 Apr; 287(18):14760-71. PubMed ID: 22351759 [TBL] [Abstract][Full Text] [Related]
8. Immunoexpression patterns for Hypoxia-inducible Factor-1α and von Hippel-Lindau protein, in relation to Hsp90, of human brain tumors. Assimakopoulou M; Androutsopoulou C; Zolota V; Matsoukas J Histol Histopathol; 2016 May; 31(5):535-46. PubMed ID: 26592496 [TBL] [Abstract][Full Text] [Related]
9. UFM1 inhibits hypoxia-induced angiogenesis via promoting proteasome degradation of HIF-1α. Jing Y; Ye K; Zhang G; Zhu J; Mao Z; Zhang Q; Chen F Mol Cell Biochem; 2024 Jul; 479(7):1833-1852. PubMed ID: 38722467 [TBL] [Abstract][Full Text] [Related]
10. COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70. van de Sluis B; Groot AJ; Vermeulen J; van der Wall E; van Diest PJ; Wijmenga C; Klomp LW; Vooijs M PLoS One; 2009 Oct; 4(10):e7332. PubMed ID: 19802386 [TBL] [Abstract][Full Text] [Related]
11. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677 [TBL] [Abstract][Full Text] [Related]
12. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway. Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262 [TBL] [Abstract][Full Text] [Related]
13. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway. Kataria N; Martinez CA; Kerr B; Zaiter SS; Morgan M; McAlpine SR; Cook KM Cell Physiol Biochem; 2019; 53(3):480-495. PubMed ID: 31486323 [TBL] [Abstract][Full Text] [Related]
14. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
15. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70. Zhang D; Li J; Costa M; Gao J; Huang C Cancer Res; 2010 Jan; 70(2):813-23. PubMed ID: 20068160 [TBL] [Abstract][Full Text] [Related]
16. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. Zhou J; Schmid T; Frank R; Brüne B J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529 [TBL] [Abstract][Full Text] [Related]
17. Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization. Liu YV; Hubbi ME; Pan F; McDonald KR; Mansharamani M; Cole RN; Liu JO; Semenza GL J Biol Chem; 2007 Dec; 282(51):37064-73. PubMed ID: 17965024 [TBL] [Abstract][Full Text] [Related]